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Abstract
Abdominal aortic aneurysms (AAAs) represent a potentially life-threatening condition that 
predominantly affects the infrarenal aorta. Several preclinical murine models that mimic the 
human condition have been developed and are now widely used to investigate AAA pathogenesis. 
Cell- or pharmaceutical-based therapeutics designed to prevent AAA expansion are currently 
being evaluated with these animal models, but more minimally invasive strategies for delivery 
could improve their clinical translation. The purpose of this study was to investigate the use of 
self-assembling type I collagen oligomers as an injectable therapeutic delivery vehicle in mice. 
Here we show the success and reliability of a para-aortic, ultrasound-guided technique for 
injecting quickly-polymerizing collagen oligomer solutions into mice to form a collagen-fibril 
matrix at body temperature. A commonly used infrarenal mouse AAA model was used to 
determine the target location of these collagen injections. Ultrasound-guided, closed-abdominal 
injections supported consistent delivery of collagen to the area surrounding the infrarenal 
abdominal aorta halfway between the right renal artery and aortic trifurcation into the iliac and tail 
arteries. This minimally invasive approach yielded outcomes similar to open-abdominal injections 
into the same region. Histological analysis on tissue removed on day 14 post-operatively showed 
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minimal in vivo degradation of the self-assembled fibrillar collagen and the majority of implants 
experienced minimal inflammation and cell invasion, further confirming this material's potential as 
a method for delivering therapeutics. Finally, we showed that the typical length and position of this 
infrarenal AAA model was statistically similar to the length and targeted location of the injected 
collagen, increasing its feasibility as a localized therapeutic delivery vehicle. Future preclinical 
and clinical studies are needed to determine if specific therapeutics incorporated into the self-
assembling type I collagen matrix described here can be delivered near the aorta and locally limit 
AAA expansion.
Graphical abstract
Introduction
Abdominal aortic aneurysms (AAAs) are pathological dilations of the aorta that are 
associated with significant morbidity and mortality (1), accounting for more than 150,000 
deaths globally in 2013 (2). Several common murine AAA models have been developed that 
mimic many characteristics of the human condition. These include chemically-induced 
AAAs with either calcium chloride (CaCl2) (3) or porcine pancreatic elastase (4,5), or 
genetically-induced in hyperlipidemic mice (6,7) infused systemically with angiotensin II 
(8–11). Current therapeutic strategies have focused on reducing extracellular matrix 
degradation and chronic inflammation (12,13), both of which are known to be important 
pathological features of AAAs (14). While most previous preclinical AAA work has 
administered experimental cell-based and pharmaceutical therapeutics through 
intraperitoneal injections (15), intravenous injections (16), or the animals' drinking water 
(17), minimally invasive injection strategies have the potential to locally deliver therapies 
with a clear translational potential (18).
Type I collagen is the major structural and mechanical determinant of the extracellular 
matrix within connective tissues (19,20). Due to its proteolytic degradability, 
biocompatibility, and low antigenicity, collagen has recently garnered interest as a clinically 
relevant biomaterial for therapeutic cell and molecule delivery (21). However, commercial 
grade monomeric collagen sources have slow polymerization rates and produce gels or 
matrices with low mechanical integrity, thus limiting their use as an injectable therapeutic 
delivery vehicle in vivo (22). Recently, a new soluble type I collagen subdomain, termed 
oligomers, has been isolated from porcine dermis (23). Oligomers uniquely retain their 
natural intermolecular crosslinks, which induce suprafibrillar self-assembly to yield highly-
branched collagen-fibril networks with improved mechanical integrity (23). Specifically, 
oligomer matrices prepared at 0.5-4 mg mL-1 exhibit shear storage modulus (G′) values of 
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40-1500 Pa compared to 2-300 Pa and 2-50 Pa for telocollagen and atelocollagen 
respectively (22). Oligomers also polymerize within minutes to form D-banded collagen-
fibril materials with tunable properties, including fibril microstructure, matrix stiffness, and 
proteolytic degradation based on the polymerization parameters such as total collagen 
concentration and oligomer to monomer ratio (22,24,25). This previous work motivates 
further investigation of oligomers as an injectable self-assembling biomaterial for 
encapsulation and delivery of therapeutics in vivo.
Over the past 20 years, the field of image-guided interventions has greatly expanded by 
advances in medical imaging technology (26). With the real-time acquisition, portability, and 
low cost of ultrasound, it has emerged as an important imaging modality both in the clinic 
(27) and in preclinical animal research (28,29) for improved location, accuracy, precision, 
and overall success of image-guided injections. Without the aid of noninvasive imaging, 
delivery is typically limited to systemic injections that are commonly associated with off-
target side effects in other organ systems (30–32) or open surgical implantation that is 
impractical with repeated treatments. Therapies delivered locally can potentially reduce 
these complications and target the aortic adventitia. Ultrasound guidance supports 
visualization of the target site and allows for minimally invasive delivery of therapies in both 
humans (33–35) and rodents (9,36–38).
In this study we describe a technique for murine para-aortic injections of self-assembling 
type I collagen oligomers with high frequency ultrasound guidance. Analysis of the success 
and reliability of these ultrasound-guided closed-abdominal injections are presented and 
compared to open injections after abdominal laparotomy. Here, success is defined as 
consistent localized delivery of the collagen volume midway between the right renal artery 
and aortic trifurcation into the iliac and tail arteries. Additionally, we present results of a 
longitudinal study designed to quantify the persistence and displacement of the formed 
collagen-fibril matrix in vivo over 14 days using high frequency ultrasound. Finally, we 
compare the length and target location of the collagen injection to the average length and 
position of an infrarenal AAA in a topical elastase mouse model (39). Our results suggest 
that injections of self-assembling oligomers via ultrasound guidance can be used as a 
minimally invasive delivery strategy within the peritoneal cavity of mice, specifically for the 
use as an infrarenal AAA therapeutic delivery vehicle. Future studies using this ultrasound-
guided technique will be needed to determine if collagen encapsulated therapeutics can limit 
AAA expansion.
Materials and Methods
Topical Elastase AAA Disease Model
Animal Procedure—Wild-type male mice (n=9; 23.9 ± 1.4 g, 10.8 ±1.1 weeks old) from 
Harlan Laboratories (Indianapolis, IN) underwent laparotomies to induce infrarenal AAAs 
using a previously described topical elastase model (39). Briefly, we exposed the infrarenal 
aorta between the renal arteries and aortic trifurcation. Once exposed, a 4×2 mm piece of 
Gelfoam (Pharmacia & Upjohn Co., Pfizer Inc., New York, NY) was soaked in 50 μL type I 
porcine pancreatic elastase (3.6 mg/mL in water [with 0.01% thymol & trypsin at ≤50 BAEE 
units/mg protein], elastase activity measured to be between 27-34 units/mL, Sigma-Aldrich 
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Co., E1250, St. Louis, MO) was applied to the aorta for 10 minutes before being rinsed with 
2 mL sterile saline. The animal was sutured closed, given a dose of carprofen (RIMADYL®, 
dose 5mg/kg, concentration 0.5mg/mL, amount 0.1mL/10g, Zoetis Inc., Kalamazoo, MI), 
and recovered. The Purdue Animal Care and Use Committee approved all procedures.
Ultrasound image collection and analysis—Ultrasound images were collected for 
each mouse before surgery and again at 3,7, and 14 days post-surgery. We collected B-mode 
and M-mode images of the infrarenal aorta in both long- and short-axis as well as short-axis 
3D images. The images were analyzed using VevoLab software (FUJIFILM VisualSonics) to 
quantify length, diameter, and volume of the aneurysm over 14 days as well as vertical 
distance from the middle of the AAA to the iliac trifurcation. B-mode volumes were lofted 
together by manually drawing serial contours using parallel segmentation (0.57 mm or 
smaller step size). The first and last contours were used to determine aneurysm length. A 
linear distance measurement tool was used to determine the diameter and vertical distance.
Collagen Injections
Animal Use and Treatment—For this study, we used a total of 18 male C57BL/6 mice 
(32.0 ± 3.9 g, 18.8 ± 3.0 weeks old) from Harlan Laboratories (Indianapolis, IN) or bred at 
Purdue University (West Lafayette, IN). Six animals received ultrasound-guided closed-
abdominal injections followed by euthanasia, six animals received open-abdominal 
injections followed by euthanasia, and six animals received ultrasound-guided closed-
abdominal injections followed by 14 days of imaging surveillance with ultrasound. All 
animals were healthy prior to injection and body mass was monitored for the six recovered 
animals throughout the study. The Purdue Animal Care and Use Committee approved all 
procedures.
Type I Collagen Preparation—Type I collagen oligomers were derived from the dermis 
of domestic pigs and prepared as described previously (22). Prior to use, lyophilized 
collagen oligomers were dissolved in 0.01 N hydrochloric acid (HCl) and rendered aseptic 
by chloroform exposure at 4°C. A Sirius Red (Direct Red 80) assay was used to determine 
collagen concentration as previously described (40). The oligomer formulation was 
standardized based upon purity as well as polymerization potential according to the ASTM 
international consensus standard F3089-14 (41). Polymerization potential is defined by 
matrix shear storage modulus (G′) as a function of collagen concentration of the 
polymerization reaction (22). The collagen solution was diluted with 0.01 N HCl and 
neutralized with both 10× phosphate buffered saline (PBS) and 0.1 N sodium hydroxide 
(NaOH) to achieve a pH of 7.4.
Oligomer polymerization kinetics were measured using an AR2000 rheometer (TA 
Instruments, New Castle, DE) equipped with a stainless-steel 40 mm-diameter parallel plate 
geometry. Upon lowering the geometry, the Peltier plate was maintained at 4°C for 5 
minutes and then increased to 37°C for 15 minutes to induce collagen polymerization. Time-
dependent changes in shear storage modulus (G′) were measured at 1% controlled 
oscillatory strain. Polymerization half-time was calculated at the time at which G′ equals 
half the maximum G′ value (n=3). Cryo-SEM images displaying oligomer matrix 
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ultrastructure were obtained using an FEI NOVA nanoSEM 200 (FEI, Hillsboro, OR) 
varying between an Everhart-Thronley (<10,000× magnification) or immersion lens 
(>10,000× magnification) detector. Samples were quick frozen by submersion into critical 
point liquid nitrogen, transferred to a CT1000 col-stage attachment (Oxford Instruments 
North America, Inc., Concord, MA), and sublimated under vacuum for 15 minutes before 
sputter coating and imaging.
All oligomers were injected at a final collagen concentration of 2.1 mg/mL and volume of 
150 μL, which yielded a 500 Pa collagen-fibril matrix. To visualize collagen following 
injection, blue food dye (Clover Valley, Dollar General Corporation, Goodlettsville, TN) was 
added to the PBS solution. Collagen solutions were kept on ice prior to injection, allowing 
for polymerization to occur once the solution warmed to body temperature (∼37°C) post-
injection.
Ultrasound-Guided Closed-Abdominal Injections
Animal Preparation—Transabdominal para-aortic injections were performed with 
ultrasound guidance in a total of 12 mice. Prior to imaging, animals were anesthetized in a 1 
L induction chamber and kept unconscious with a coaxial nose cone non-rebreathing system 
that administered 1-3% isoflurane in 1.5 L/min medical grade air. Sterile eye lubricant was 
applied and animals were positioned on an adjustable heated stage set to 44°C to maintain 
internal body temperature near 37°C. Heart rate, respiration rate, and body temperature were 
monitored every 15 minutes with stage electrodes and a rectal probe, respectively. Hair on 
the ventral and dorsal sides was removed with clippers and depilatory cream (Nair, Church 
& Dwight Co., Inc. Ewing, NJ). Warm ultrasound transmission gel was applied liberally to 
the exposed skin prior to transducer placement.
Pre- and Post-Injection Imaging—For detection and monitoring of material injections, 
we used a high-resolution small animal ultrasound system (Vevo2100, FUJIFILM 
VisualSonics, Toronto, Canada) with a linear array transducer (MS550D, 256 elements, 40 
MHz center frequency). Prior to injection, the right renal artery and aortic trifurcation were 
visualized in short axis on all animals positioned supine. To obtain animal-specific 
measurements, we used the y-axis stage controller to measure the length from the right renal 
artery to aortic trifurcation in millimeters. This total infrarenal aortic length was used to 
calculate a midpoint of the infrarenal aorta for each animal, the target location of our 
injection strategy. For baseline pre-injection ultrasound scans, transaxial three-dimensional 
B-mode images were acquired with respiration and cardiac gating from all animals (0.19 
mm step size, 20 mm scan distance from the right renal artery to aortic trifurcation). 
Additionally, two-dimensional B-mode cine loops (100 frames) were acquired to the left and 
right of the infrarenal aorta in long axis. Similar three- and two-dimensional B-mode images 
were acquired on all animals post-injection and on the six recovered animals at days 1, 2, 3, 
7, and 14 post-injection. The angle of the animal stage was adjusted for optimal aortic 
visualization and M-mode, color Doppler, and pulsed-wave Doppler acquisitions were used 
to discriminate arteries from veins.
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Injection Procedure—Following baseline imaging, all animals were positioned prone and 
the stage was angled approximately 10° to the right. The transducer was clamped to an 
adjustable bench-mounted rail system, angled approximately 45° to the left, and positioned 
in a mediolateral orientation on all animals in short axis (Fig 1). The infrarenal aorta 
midpoint was visualized with B-mode and distinguished from the vena cava with M-mode 
and color Doppler. We adjusted the imaging depth between 10-11 mm to optimize aorta 
visualization.
An automated image-guided precision micro-injection system (FUJIFILM VisualSonics) 
was mounted to the left of the animal stage and used for all closed-abdominal injections. For 
accurate needle placement, an empty 1 mL syringe with a 27 G, ½ in. sterile needle was 
positioned in line with the transaxial plane of the transducer and angled approximately 45° 
downward parallel to the transducer (Fig 1). The injection mount controls were used to 
advance the needle directly under the transducer, requiring only minor adjustments of the 
transducer to enhance visualization of the needle tip in contact with the skin. Prior to 
breaking the skin surface, the trajectory of the needle was adjusted and visually aligned to 
ensure accurate placement with minimal injury. The needle was then inserted through the 
abdominal wall on the left side and positioned directly above the infrarenal aorta towards the 
animal's ventral side (Fig 2).
Following needle alignment, we loaded 150 μL of oligomer solution into a 1 mL syringe 
with a 27 G, ½ in. sterile needle that was pre-chilled in a -20°C freezer. The collagen filled 
syringe and needle were then clamped into the injection mount system with the bevel up, 
ensuring no adjustments were needed for alignment. We then inserted the needle tip directly 
above the infrarenal aorta and injected 150 μL of oligomeric collagen. A 440-500 frame B-
mode cine loop was acquired both during injection and needle withdrawal for all para-aortic 
injections with a single focal zone on the aorta (S1 and S2 Videos). No para-aortic injections 
were performed on the right side of animals to serve as an internal control.
Conventional Open-Abdominal Injections
Animal Preparation—Para-aortic injections were performed in six mice without 
ultrasound guidance during an open-abdominal surgery approach. Animals were 
anesthetized and kept unconscious with isoflurane and medical grade air as mentioned 
above. A 50 W heating pad warmed to approximately 40°C was used to maintain internal 
body temperature at 37°C. The rate of respiration was monitored visually and the depth of 
anesthesia was assessed with periodic toe pinches. Aseptic technique was not followed for 
this non-recovery procedure, but hair on the ventral side was removed with depilatory cream.
Injection Procedure—The infrarenal aorta was surgically exposed and oligomeric 
collagen was prepared as described above. To mimic the closed-abdominal injections, the 
needle was manually guided through the abdomen from the left and positioned directly on 
top of the infrarenal aorta with the bevel down. Collagen was injected at the midpoint of the 
infrarenal aorta and a stereomicroscope (M60 with DFC290HD camera, Leica 
Microsystems, Wetzlar, Germany) was used to capture images before, during, and 5 minutes 
after the 150 μL para-aortic injection (Fig 3).
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Animal Sacrifice and Dissection
We anesthetized all animals with isoflurane before euthanasia in a 1 L induction chamber 
with 0.2 L/min carbon dioxide following injection (n=12) or 14 days after recovery (n=6). 
The abdominal aorta from the suprarenal region down to the aortic trifurcation (including 
the kidneys, collagen injection, and all surrounding tissue) was carefully dissected and 
imaged with the same stereomicroscope. The abdominal tissue was fixed in 4% 
paraformaldehyde for 24 hours and then transferred to 0.1% paraformaldehyde for long-term 
storage. The spine was also removed from the fixed tissue prior to histological sectioning.
Histology Preparation and Staining
Fixed abdominal tissue at the target location (approximately 3 mm long and 20 mm wide) 
was dissected for sectioning. The tissues were oriented diagonally in single-chamber 
histology cassettes, held in place with foam biopsy pads, and stored in 0.1% 
paraformaldehyde until processing. The abdominal segments were then paraffin-embedded, 
thin-sectioned (5 μm), and adjacent sections were stained with hematoxylin and eosin 
(H&E) and Masson's trichrome (MTC) with an aniline blue staining kit (lot number 
1528839, Newcomer Supply, Middleton, WI). The MTC stain was used to differentiate 
collagen (blue) from surrounding structures. We imaged stained tissue sections at both 10× 
and 40× magnification with a compound microscope (DM750 with ICC50W camera, Leica 
Microsystems).
Ultrasound Analysis and Validation
Post-injection ultrasound data was analyzed for days 0, 3, 7, and 14 with VevoLab software 
to quantify collagen implant dimensions (i.e. length, width, height) and volume. Both the 
vertical distance from the center of the collagen to the center of the infrarenal aorta and the 
closest horizontal distance from the aorta to the collagen were also measured to define 
implant displacement over the two-week period. B-mode volumes of collagen were 
segmented as mentioned above. The first and last contours were used to determine implanted 
collagen length. A linear distance measurement tool was used to determine the width, 
height, and displacement distances.
To validate the volume measurements, polyethylene tubing (PE50, Braintree Scientific, 
Braintree, MA) filled with oligomeric collagen was imaged with transaxial three-
dimensional B-mode ultrasound (0.19 mm step size, 20 mm scan distance). The collagen 
volume was segmented manually by drawing serial contours and compared to the known 
volume calculated from the inner diameter and length of the tubing.
Dissection Image Analysis
Microscope images taken from dissection were analyzed with ImageJ software (42) to 
determine implanted collagen length, and horizontal and vertical collagen displacement 
distances from the infrarenal aorta. All images were accurately scaled prior to analysis and 
the straight line tool was used to measure distances.
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Statistical Analysis
Data are represented as mean ± standard deviation (SD) and Minitab statistical software 
(Minitab, version 17) was used for all analysis. One-way ANOVA tests with post hoc Tukey 
comparisons were run to assess statistical significance of parameters between two time 
points or treatment groups. For all tests, we considered a p-value less than 0.05 to be 
significant.
Results
Oligomer exhibits rapid supramolecular self-assembly, transitioning from a solution to a 
continuous D-banded collagen-fibril scaffold
The fibrillar and suprafibrillar self-assembly displayed by type I collagen oligomers has the 
potential to provide the necessary microstructure and mechanical support for controlled 
drug, nanoparticle, or cell delivery. Since oligomers start as a viscous solution, they show 
excellent flowability even through small gauge needles, making them ideally suited for 
minimally invasive procedures. Upon warming body temperature (37°C), oligomers rapidly 
self-assemble with a polymerization half-time of 0.62±0.03 minutes as measured using a 
rheometer-based method. Ultrastructure analysis using cryo-SEM reveals that oligomers 
form a highly interconnected fibrillar scaffold with D-spacing patterns similar to those found 
within connective tissues in vivo (Figure 4).
Elastase AAA Develop Midway Between the Renal Arteries and Aortic Trifurcation
Using the collected ultrasound images, we found the average length of the AAAs to be 8.3 
± 1.13 mm over 14 days (Fig 5(e)). We also found that the average diameter (day 0: 0.66 
±0.05 mm, day 7: 0.97 ± 0.04 mm, day 14: 1.13 ± 0.13 mm) and volume (day 0: 2.31 ±0.40 
mm3, day 7: 5.08 ± 0.79 mm3, day 14: 6.63 ± 1.37 mm3) of these infrarenal aneurysms 
increased significantly from day 0 to day 14 (p < 0.05; Fig 5(a, b)). The average vertical 
distance from the middle of the AAAs to the start of the iliac arteries was 6.73 ± 1.18 mm 
(Fig 5(d)), which served as our target location for the collagen injection studies.
Ultrasound-Guided Injections Can Reliably Deliver Type I Collagen
For the closed-abdominal injections with (n=6) and without recovery (n=6), the midpoint of 
the infrarenal aorta and needle were easily distinguished in all animals and 92% (11 out of 
12) of the injections could be visualized with ultrasound. We defined injection visualization 
as the formation of a growing hypoechoic region gradually separating the needle from the 
infrarenal aorta in synchrony with the injection of collagen. This formation caused the 
infrarenal aorta to shift, typically to the right and dorsally (S1 Video). Three-dimensional B-
mode scans enabled us to visualize and analyze the hypoechoic implanted collagen and 
infrarenal aorta in all animals post-injection (S3 Video). Following injection on day 0, the 
collagen had a quantified mean volume of 45.2 ± 14.0 mm3 that spanned a mean length of 
9.0 ± 2.2 mm. Mean collagen width and height values were 5.3 ± 1.5 mm and 3.9 ± 1.0 mm, 
respectively. The mean horizontal distance between the collagen and the infrarenal aorta was 
1.0 ± 0.8 mm, and the center of the collagen was, on average, 1.7 ± 0.9 mm distal to the 
center of the infrarenal aorta. To validate the volumetric ultrasound results, we measured the 
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polyethylene tubing (0.5842 mm inner diameter, 20 mm length) filled with oligomeric 
collagen to have an inner volume of 5.35 mm3, which compared well with the known inner 
volume of 5.36 mm3.
Ultrasound-Guided Closed-Abdominal Injections Are Similar to Open-Abdominal Injections
Measurements taken from dissection images showed no statistical differences between the 
collagen for the closed-abdominal and open-abdominal injections without recovery (Fig 
6(a)). The mean length of the collagen implant was similar for both groups (closed-
abdominal: 9.0 ± 0.7 mm and open-abdominal: 8.5 ± 3.0 mm, p = 0.70). We found that the 
collagen was slightly closer to the aorta in the open-abdominal group in the horizontal 
direction, but this did not reach statistical significance (closed-abdominal: 1.3 ± 1.3 mm and 
open-abdominal: 0.4 ± 0.6 mm, p = 0.14). Finally, the vertical displacement of the collagen's 
center towards the animal's tail from the infrarenal aorta's center was similar for both closed- 
and open-abdominal injections (closed-abdominal: 1.1 ± 0.3 mm and open-abdominal: 1.2 
± 0.9 mm, p = 0.74). Sample closed-abdominal and open-abdominal dissection images are 
shown in Figure 6(b, c).
Small Animal Ultrasound Enables Longitudinal Monitoring of Type I Collagen In Vivo
For the closed-abdominal injections with recovery, all six animals were fully ambulatory 
with no signs of complications. Average body mass went from 31 ± 4.1 g at day 0 pre-
injection to 29 ± 3.2 g two days after injection, but then increased to 31 ± 2.4 g 14 days after 
injection. Three-dimensional B-mode scans on subsequent study days facilitated temporal 
monitoring of collagen injections (Fig 7). One of the animals had a substantial amount of 
abdominal gas at each time point, which prevented us from analyzing the ultrasound images, 
reducing the total number to five. Over the course of 14 days, the collagen volume (day 0: 
49.5 ± 6.8 mm3 to day 14: 51.8 ± mm3, p = 0.58) did not change significantly (Fig 7(a)). 
The length (day 0: 7.9 ± 1.3 mm to day 14: 8.1 ± 0.9 mm, p = 0.75), width (day 0: 5.9 ± 1.3 
mm3 to day 14: 5.2 ± 0.5 mm3, p = 0.30), and height (day 0: 3.7 ± 0.9 mm3 to day 14: 4.5 
± 1.4 mm3, p = 0.30) of the collagen also showed no significant difference over the 14-day 
period (Fig 7(b)). The collagen's distance from the aorta in both horizontal and vertical 
directions was also tracked, which indicated collagen implant displacement insignificantly 
leftward (1.1 ± 0.9 mm to 2.4 ± 1.0 mm, p ≤ 0.06) and significantly distally (1.9 ± 0.6 mm to 
3.9 ± 0.3 mm, p ≤ 0.001) from the infrarenal aorta's center over 14 days (Fig 7(c)). 
Ultrasound measurements for recovery and non-recovery animals were compared to their 
respective dissection image measurements to further validate our method. Non-recovery 
group length (dissection: 9.0 ± 0.7 mm and ultrasound: 9.8 ± 2.5 mm, p =0.46), horizontal 
displacement (1.3 ± 1.3 mm and 0.9 ± 0.8 mm, p =0.57), and vertical displacement (1.1 
± 0.3 mm and 1.5 ± 1.1 mm, p =0.42), as well as recovery group length (7.5 ± 1.9 mm and 
± 0.9 mm, p = 0.49), horizontal displacement (1.5 ± 0.2 mm and 2.4 ± 1.0 mm, p = 0.06) 
were all found to be statistically similar for dissection image and ultrasound image analyses. 
The vertical displacement in the recovery group (1.9 ± 1.2 mm and 3.9 ± 0.3 mm, p ≤ 0.01) 
was found to be statistically different between the dissection and ultrasound measurements. 
(Fig 8(a,b)). Representative ultrasound and dissection images from the closed-abdominal 
injections on days 0 and 14 are shown in Figure 8(c-f).
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Histological cross-sections obtained on day 14 showed that the injected collagen was similar 
in appearance to the fibrillar collagen found in normal dense connective tissues (i.e., 
dermis). Leukocytes, mainly neutrophils, surrounded but did not invade the collagen 
implants at day 14 in the majority (5 out of 6) of recovery animals (Fig 9(a,b)). Only one 
recovery mouse had leukocytes infiltrating the injected collagen at day 14 (Fig 9(c,d)). 
Intralesional bacteria and focal collagen degradation were also observed to invade the 
collagen implant within this mouse.
Collagen Injection Location and Length Similar to AAA Model
We compared the location of the middle of the AAA to the middle of the collagen injections 
by measuring their respective distances above the iliac artery bifurcation (AAA: 6.73 ± 1.18 
mm; collagen injection: 7.28 ± 0.38 mm) and found no statistically significant difference (p 
= 0.15; Fig 4(d)). When compared to the collagen implant, the average length (AAA: 8.30 
± 1.18 mm; collagen injection: 8.11 ± 0.88 mm) was also not significantly different (p = 
0.77; Fig 4(e)).
Discussion
This work demonstrates utility of high frequency ultrasound for guidance and temporal 
monitoring of transabdominal para-aortic self-assembling type I collagen implants in mice. 
We showed that closed-abdominal injections with an ultrasound-guided technique delivered 
highly reproducible volumes of type I collagen oligomers to a target location near the 
infrarenal aorta. The outcomes of this minimally invasive approach, specifically reliable and 
reproducible volume delivery and localization, were similar to open-abdominal surgical 
injection strategy, showing our collagen could be placed similarly with ultrasound guidance 
without major surgery to administer a therapeutic.
Persistence of the injected collagen implant over a 14-day period was also documented with 
longitudinal ultrasound studies. The majority of recovery animals exhibited little to no cell 
invasion into the collagen implant, with one mouse showing more substantial leukocyte 
infiltration. Material persistence, together with the lack of significant cellular infiltration and 
minimized inflammatory response is especially noteworthy since conventional biologic-
based injectables, including suspensions of decellularized tissue particulate or insoluble 
fibrillar collagens, are often associated with significant inflammatory/foreign body reactions 
and/or rapid degradation. These tissues responses are often characterized by dense 
infiltration of neutrophils, macrophages, and, in some cases, giant cells. Remnant cellular 
components (i.e., DNA) and/or extent of processing (i.e., exogenous crosslinking) have been 
implicated as the cause of these inflammatory/foreign body reactions (43). In contrast, 
oligomer collagen represents a highly purified formulation with defined molecular 
composition. This purified collagen, which is highly conserved across species (44), appears 
to eliminate many of the components known to induce adverse tissue responses and rapid 
degradation. Material sterilization, rather than aseptic preparation, and refinement of sterile 
injection may further assist in reducing overall inflammation in future studies. Taken 
together, these results suggest that this ultrasound-guided technique is an effective approach 
for delivery near the infrarenal aorta. Given this, further investigation will be needed to 
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determine if self-assembling type I collagen oligomers can be used as an injectable 
therapeutic delivery vehicle.
The infrarenal AAAs analyzed for this study showed a significant increase in the diameter 
and volume of the aorta midway between the renal and iliac arteries. This helped us identify 
our target for the collagen injections as 6.7 mm above the iliac bifurcation. The results of the 
collagen portion of this study revealed that we were able deposit an implant with a 
minimally invasive approach near the midpoint of the infrarenal aorta (the same location as 
the formation of the elastase-induced aneurysms). Furthermore, the comparable average 
lengths of the AAAs and the collagen implants showed that the polymerized collagen would 
be of adequate length to locally affect the entire AAA, not just a small region. Thus, this 
collagen injection technique could easily be paired in future studies with an infrarenal AAA 
model to test the efficacy and applicability of unproven controlled release therapeutics.
The clinical utility of para-aortic delivery of therapeutics via a trans-abdominal or trans-
lumbar approach is significant, as others have noted (18). AAA is characterized by mural 
infiltration of cytotoxic T-cells, dendritic cells, and macrophages and current data suggests 
that it is the result of a dysregulated auto-immune response to a cryptic antigen(s). The 
resultant inflammatory cascade, with production of reactive oxygen species and proteases, 
leads to smooth muscle cell apoptosis and degradation of the extra-cellular matrix proteins. 
It is this latter process that leads to loss of the structural integrity of the aortic wall and 
pathological dilatation. A minimally invasive approach with ultrasound-guided placement of 
a needle through the lumbar muscles could deliver immunomodulatory cells, such as 
mesenchymal stromal cells or T regulatory cells, that can mitigate the inflammatory cell 
activity in its initiation (13). Intravenous delivery of cells results in significant pulmonary 
sequestration, as we have previously shown, whereas needle directed para-aortic delivery 
will concentrate cells near the aorta and may increase their potency (45).
When polymerized, type I collagen oligomers from porcine skin form an interconnected 
fibril network demonstrating mechanical integrity far exceeding that of conventional 
monomer collagen formulations (22). Previous work has shown that oligomeric collagen has 
tunable properties, including fibril microstructure, matrix stiffness, and proteolytic 
degradation, which are all known to influence cell fate (24,46). Kreger et al. showed that 
mesenchymal stem cells (MSCs) are able to sense and respond to the broad range of 
physical properties provided by collagen-fibril matrices and that these properties provide 
important guidance cues for fundamental MSC behavior in vitro, including lineage specific 
differentiation of MSCs in vitro (22). This suggests that the self-assembling collagen could 
be used as an effective in vivo delivery vehicle for MSCs while supporting modulation of 
fibril density and matrix stiffness. With their immunosuppressive activities, MSCs have been 
shown to improve the outcome of inflammation-based diseases such as aortic aneurysms by 
administration through tail-vein injections (13) and topical placement of MSC sheets (47), 
thus opening the door to investigate the translational potential of MSCs delivered with 
oligomeric collagen as a treatment strategy for AAAs. Future studies could also investigate 
oligomeric collagen as a localized delivery vessel for therapies such as microRNAs, 
monoclonal antibodies, and various small molecules for treating a variety of diseases 
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including cardiac remodeling (48), several cancers (49,50), diabetes (51), and Alzheimer's 
disease (52).
Despite the efficacy of our ultrasound-guided injections, some limitations in the present 
study remain. First, the presence of abdominal gas can disrupt ultrasound imaging. While 
some adjustment of the animal stage relative to the transducer can minimize this 
interference, this artifact sometimes remained unresolved and limited our ability to visualize 
the collagen implant. Optimal collagen visualization is crucial for accurate ultrasound 
analysis and a lack thereof could explain the difference between the polymerized collagen 
volume quantified (45.2 ± 14.0 mm3) and the total collagen solution volume injected (150 
mm3). Another possible explanation for this volume discrepancy is the loss of interstitial 
fluid and compression of the formed collagen-fibril network upon injection within the 
confined tissue space. To better distinguish implanted collagen from surrounding structures, 
encapsulated gas-filled microbubbles could be used as a contrast agent, an approach that has 
become common in clinical imaging (53). Furthermore, compression of mice with the 
ultrasound probe could cause deformation of the collagen implant in vivo. Because of this, 
we made a strong effort to reduce the amount of pressure the transducer exerted on each 
mouse to diminish deformation. Finally, visualization of the injection, important for 
ensuring accurate collagen delivery, can be hindered by attenuation from the spine. We were 
able to visualize 92% (11 out of 12) of the closed-abdominal injections at the target site, 
suggesting that the spine did not create a major issue. In the one animal where the injection 
was not visualized with ultrasound, collagen was also not detected at the target location, 
suggesting inaccurate delivery. Because these injections are minimally invasive, an injection 
in future studies can always be repeated to ensure proper administration.
Conclusions
We demonstrated the utility of ultrasound-guided methods for successful and reliable 
delivery of self-assembling type I collagen oligomers to the region surrounding the 
infrarenal aorta in mice, based on a commonly used infrarenal AAA model. Our injected 
collagen implants had similar lengths as an infrarenal AAA and were delivered within close 
proximity to the aorta. In a longitudinal study, polymerized oligomer matrices persisted with 
insignificant proteolytic degradation and minimal inflammation and cell invasion over a two-
week period. With advancements in tissue engineering and medical imaging, future studies 
could use this injection technique to develop and investigate novel therapeutics for AAAs 
and other diseases.
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Fig 1. Set-up for ultrasound-guided closed-abdominal injections
An anesthetized mouse is shown on the animal stage. The ultrasound transducer as well as 
the syringe and needle are shown placed above the animal ready for injection.
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Fig 2. Ultrasound visualization of needle alignment in relation to infrarenal aorta pre-injection
Two-dimensional B-mode image in short axis showing the ultrasound-guided insertion of a 
27 G needle (yellow arrows) through the abdomen and positioned directly above the 
infrarenal aorta (red arrow) towards the ventral side. The black shadow in the middle of the 
image represents signal attenuation from the spine. A single focal zone was set 7 mm deep at 
the injection target site.
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Fig 3. Open-abdominal injection of type I collagen during surgical procedure
Three stereomicroscope images show the surgical approach before (a), during (b), and 5 
minutes after (c) an open-abdominal injection of oligomeric collagen (blue arrow). A 27 G 
needle (yellow arrows) with the bevel down was inserted through the abdomen from the left 
and positioned directly on top of the infrarenal aorta (red arrow). Scale bars = 5 mm.
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Fig 4. Type I collagen oligomers form highly interconnected fibrillar matrices
High resolution cryo-SEM images showing the type I collagen oligomers forming highly 
interconnected fibrillar matrices with D-periodic spacing similar to that found in connective 
tissues in vivo. Scale bars are 30 μm (a) and 1 μm (b), respectively.
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Fig 5. Infrarenal AAA Model Guides Collagen Injection Target
Mean ± SD for US measurements of AAA diameter (a) and volume (b) over 14 days. 
Example infrarenal AAA volume expansion is depicted over the same two weeks (c). Mean 
± SD for comparisons between AAA and collagen implant length (d) as well as comparison 
between the distance above the iliac arteries for the middle of the AAA and the target of 
each collagen injection (e). Scale bars= 2 mm (c). * denotes statistical significance of AAA 
measurements between day 0 and 14 (p < 0.05).
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Fig 6. Comparison between closed-abdominal and open-abdominal injections
The mean ± SD (n=6) measurements for collagen, including implant length, and horizontal 
and vertical displacement from the aorta, were similar between closed-abdominal and open-
abdominal injections in the non-recovery groups (a). No statistical differences between 
groups were observed (p-value range: 0.14-0.74). Representative closed-abdominal (b) and 
open-abdominal (c) dissection images show this similarity. Blue arrows point to the 
collagen, and red arrows point towards the infrarenal aorta. Scale bars = 0.5 mm.
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Fig 7. Type I collagen does not degrade significantly over 14 days in vivo
Mean ± SD measurements on days 0, 3, 7, and 14 (n=5) for collagen volume (a) and length, 
width, and height (b), as well as horizontal and vertical displacement distances (c). * denotes 
statistical significance of collagen measurements between day 0 and 14 (p < 0.05).
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Fig 8. Type I collagen displacement over 14 days in vivo quantified through dissection and 
ultrasound image analysis
Mean ± SD measurements for dissection and ultrasound (US) image measurements of 
length, and horizontal and vertical displacements at end-point for non-recovery (a, n=6) and 
recovery (b, n=6) animals. Sample three-dimensional renderings for day 0 (c) and day 14 (d) 
showing the right renal artery (top arrow) and aortic trifurcation (bottom arrow) for 
reference points and leftward and distal shift of the collagen over two weeks in vivo. 
Example dissection images of collagen injection at day 0 (e) and day 14 (f) again 
emphasizing the collagen's shift leftward and distally (blue arrow) from the infrarenal aorta 
(red arrow). Scale bars = 2 mm (c,d) and 5 mm (e,f). * denotes statistical significance of 
collagen displacement measurements between day 0 and 14 (p < 0.05)
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Fig 9. Representative histology images show range of leukocyte infiltrate at 14 days post-
injection
MTC stained histology images depict representative cell infiltrate observed 14 days after 
collagen injection. The majority of collagen implants showed surrounding leukocytes with 
little to no cell invasion (a,b). One mouse showed leukocyte infiltration (blue arrow), 
bacteria aggregation (red arrow), and possible collagen degradation (black arrow) (c,d). Mild 
(a,b) and advanced (c,d) cell infiltrate are shown at 10× (a,c) and 40× times; (b,d) 
magnification. Scale bars = 0.1 mm (a,c) and 0.05 mm (b,d).
Yrineo et al. Page 24
J Control Release. Author manuscript; available in PMC 2018 March 10.
VA A
uthor M
an
u
script
VA A
uthor M
an
u
script
VA A
uthor M
an
u
script
